WorldCat Identities

Finger, Paul T.

Overview
Works: 9 works in 18 publications in 2 languages and 327 library holdings
Roles: Editor, htt, Author, Other
Publication Timeline
.
Most widely held works by Paul T Finger
Surgical ophthalmic oncology : a collaborative open access reference by Sonal S Chaugule( )

10 editions published in 2019 in English and Undetermined and held by 316 WorldCat member libraries worldwide

Designed as an easy-to-use, practical guide to tumors of the eye, lids, and orbit, this Open Access book comprehensively addresses surgical treatment and management of diseases related to ophthalmic oncology. Surgical Ophthalmic Oncology: A Collaborative Open Access Reference is an ideal reference for general ophthalmologists, surgeons, fellows and trainees around the world who encounter these diseases in the care of their patients. Notably, this book includes considerations for those ophthalmologists offering subspecialty care in environments with limited access to advanced technology and instrumentation. Individual chapters address diagnostic indications, pre-operative and post-operative concerns, and provide detailed explanations of surgical techniques required to manage various eye cancer ailments with help of ample illustrations. High-quality videos included throughout the book provide readers with the opportunity to review surgical steps in real-time as a learning tool. Chapters thoroughly cover tumors of eyelid, cornea and conjunctiva, orbit as well as intraocular tumors, while later chapters discuss ophthalmic radiation therapy. The book concludes with a section on ophthalmic pathology which details essential guidelines on relevant aspects from specimen collection and transport, to interpretation of the pathology report. Surgical Ophthalmic Oncology: A Collaborative Open Access Reference is a unique and necessary valuable resource for ophthalmologists, trainees, and related medical professionals working in underserved areas in providing quality care for patients suffering from ocular cancers
A 5.8 GHz ophthalmic microwave applicator for treament of choroidal melanoma by Paul T Finger( Book )

1 edition published in 1983 in English and held by 2 WorldCat member libraries worldwide

Cancers of the eye by Abhilasha Maheshwari( )

1 edition published in 2018 in English and held by 2 WorldCat member libraries worldwide

Checkpoint inhibition immunotherapy for advanced local and systemic conjunctival melanoma: a clinical case series by Paul T Finger( )

1 edition published in 2019 in English and held by 2 WorldCat member libraries worldwide

Anterior segment tumors by Flavio A Marigo( )

1 edition published in 2010 in English and held by 1 WorldCat member library worldwide

Author's Reply to: Effectiveness of Anti-VEGF Treatment on Ophthalmic Radiation Side Effects( )

in English and held by 1 WorldCat member library worldwide

Láser para tumores intraoculares by Susan Schneider( )

1 edition published in 2005 in Spanish and held by 1 WorldCat member library worldwide

Intravitreal Anti-VEGF Therapy for Macular Radiation Retinopathy: A 10-Year Study( )

in English and held by 1 WorldCat member library worldwide

Purpose To report long-term experience with intravitreal anti-vascular endothelial growth factor treatment for radiation maculopathy. Methods From 2005-2015, 120 consecutive patients underwent intravitreal anti-VEGF therapy for radiation maculopathy. Inclusion criteria included a diagnosis of uveal melanoma treated with plaque radiotherapy and subsequent macular radiation vasculopathy (exudate, retinal hemorrhage, intraretinal microangiopathy, neovascularization, edema). Anti-VEGF therapy involved continuous injections in 4- to 12-week intervals with doses of 1.25 mg/0.05 mL, 2.0 mg/0.08 mL, 2.5 mg/0.1 mL, or 3.0 mg/0.12 mL of bevacizumab as well as 0.5 mg/0.05 mL or 2.0 mg/0.05 mL of ranibizumab. Goals were maintenance of visual acuity and normative macular anatomy. Safety and tolerability (retinal detachment, hemorrhage, infection), visual acuity, central foveal thickness on optical coherence tomography imaging, and clinical features of radiation maculopathy were analyzed. Results Progressive reductions in macular edema, hemorrhages, exudates, cotton-wool spots, and microangiopathy were noted. At last follow-up, 80% remained within 2 lines of their initial visual acuity or better, with a mean treatment interval of 38 months (range 6-108 months). Kaplan-Meier analysis of the probability of remaining within 2 lines of initial visual acuity was 69% at 5 years and 38% at 8 years of anti-VEGF therapy. Discontinuation of therapy was rare. Relatively few acute or long-term side effects were noted, allowing for good long-term patient accrual. Conclusions Continuous intravitreal anti-VEGF therapy in patients with radiation maculopathy was well-tolerated and preserved vision. In most cases, reductions or resolution of retinal hemorrhages, cotton-wool spots, and retinal edema were noted for up to 10 years
Angled Transscleral Intravitreal Injection: A Crossover Study( )

in English and held by 1 WorldCat member library worldwide

Purpose The perfect intravitreal injection delivers an exact amount of medication with the least risk to vision and the eye. We examined 2 different methods of intravitreal injection to determine if an angled transscleral entry for intravitreal injection results in less egress of intravitreal contents, including medication. Methods In a crossover controlled trial at an outpatient clinical facility within a major ophthalmology referral center, we treated 10 patients. The surgical technique involved injecting 0.05 mL of bevacizumab injected in one eye by both an orthogonal (straight in) and oblique (angled) technique. The intraocular pressure (IOP) was measured immediately before and after each monthly injection. Results Orthogonal injections raised the IOP significantly less (mean 24.6 mm Hg or 126%) than oblique injections (29.6 mm Hg or 152%) (p = 0.045). There were no reported differences in injection-related pain or adverse effects between the techniques. Conclusions Oblique or angled injections caused a larger IOP rise than straight or orthogonal injections. This finding suggests that oblique injections are self-sealing, deliver a higher dose of medication, or prevent vitreous reflux as well as close a potential portal of entry for pathogens
 
Audience Level
0
Audience Level
1
  Kids General Special  
Audience level: 0.58 (from 0.57 for Surgical o ... to 0.97 for Surgical o ...)

Languages